Retrospective Study
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Jan 7, 2022; 10(1): 155-165
Published online Jan 7, 2022. doi: 10.12998/wjcc.v10.i1.155
Characterization of focal hypermetabolic thyroid incidentaloma: An analysis with F-18 fluorodeoxyglucose positron emission tomography/computed tomography parameters
Haejun Lee, Yoo Seung Chung, Joon-Hyop Lee, Ki-Young Lee, Kyung-Hoon Hwang
Haejun Lee, Kyung-Hoon Hwang, Department of Nuclear Medicine, Gachon University College of Medicine, Gil Medical Center, Incheon 21565, South Korea
Yoo Seung Chung, Joon-Hyop Lee, Department of Endocrine Surgery, Gachon University College of Medicine, Gil Medical Center, Incheon 21565, South Korea
Ki-Young Lee, Department of Endocrinology and Metabolism, Gachon University College of Medicine, Gil Medical Center, Incheon 21565, South Korea
Author contributions: Lee H and Hwang KH contributed to this work; Lee H and Hwang KH designed the research study; Lee H, Chung YS, Lee JH, Lee KY and Hwang KH performed the research; Lee H contributed analytic tools; Lee H, Chung YS, Lee JH, Lee KY and Hwang KH analyzed the data and wrote the manuscript; and all authors have read and approved the final manuscript.
Institutional review board statement: This retrospective study was approved by the institutional review board of our hospital (IRB no. GAIRB2020-297), and the requirement to obtain informed consent was waived. The study was conducted in accordance with the 1964 Declaration of Helsinki and later amendments.
Informed consent statement: The requirement to obtain informed consent was waived.
Conflict-of-interest statement: The authors have no potential conflicts of interest to disclose.
Data sharing statement: Technical appendix, statistical code, and dataset available from the corresponding author at [forrest88@hanmail.net].
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Kyung-Hoon Hwang, MD, Professor, Department of Nuclear Medicine, Gachon University College of Medicine, Gil Medical Center, Namdong-daero 774 beon-gil, Namdong-gu, Incheon 21565, South Korea. forrest88@hanmail.net
Received: August 19, 2021
Peer-review started: August 19, 2021
First decision: September 29, 2021
Revised: October 9, 2021
Accepted: November 22, 2021
Article in press: November 22, 2021
Published online: January 7, 2022
Processing time: 133 Days and 4.4 Hours
ARTICLE HIGHLIGHTS
Research background

Thyroid incidentaloma (TI) is detected on imaging studies for non-thyroid purposes and the lesion may harbor a risk of malignancy. It is critical to distinguish malignant TI from benign disease.

Research motivation

The higher the metabolism on F-18 fluorodeoxyglucose (FDG) positron emission tomography-computed tomography (PET-CT) image, the higher the possibility of malignancy. TI might be characterized depending on the FDG metabolism.

Research objectives

To distinguish malignant hypermetabolic TIs from benign disease by analyzing F-18 FDG PET-CT parameters and to identify a cut-off value.

Research methods

The values of parameters from FDG PET-CT of 46 focal hypermetabolic thyroid lesions were measured, calculated, and compared. Receiver operating characteristic (ROC) curve was plotted to determine a cut-off value.

Research results

Standardized uptake value (SUV)max was the only statistically significant discriminator in differentiation. From the ROC curve, the AUC was 0.702 and the SUVmax cut-off value was 8.5.

Research conclusions

TIs with SUVmax above the cut-off value 8.5 may have a greater than 70% chance of malignancy. A further active assessment is required.

Research perspectives

Other studies and controversies on the parameters included in this study are ongoing. Further studies with a large number of subjects are guaranteed.